Satter Muneer A
Insider CIK 1315797 · VTL Director, 10% owner · TKAI 10% owner · ALRN See Remarks, Director, 10% owner · NONE Director, 10% owner · AKBA Director · ANNX Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ANNX Annexon, Inc. | A Award deriv | 2026-06-11 | 2026-06-15 | 65,000 | — | $0 | 65,000 | SEC↗ |
| ANNX Annexon, Inc. | P Buy | 2026-05-28 | 2026-05-29 | 613,497 | $5.41 | $3.32M | 10,342,134 | SEC↗ |
| ANNX Annexon, Inc. | P Buy | 2025-11-21 | 2025-11-21 | 422,613 | $4.28 | $1.81M | 9,728,637 | SEC↗ |
| ANNX Annexon, Inc. | P Buy | 2025-11-20 | 2025-11-21 | 400,000 | $4.48 | $1.79M | 9,306,024 | SEC↗ |
| ANNX Annexon, Inc. | P Buy | 2025-11-19 | 2025-11-19 | 500,000 | $3.94 | $1.97M | 8,906,024 | SEC↗ |
| ANNX Annexon, Inc. | P Buy | 2025-11-18 | 2025-11-19 | 500,000 | $3.18 | $1.59M | 8,406,024 | SEC↗ |
| ANNX Annexon, Inc. | P Buy | 2025-11-17 | 2025-11-19 | 500,000 | $2.99 | $1.50M | 7,906,024 | SEC↗ |
| ANNX Annexon, Inc. | A Award deriv | 2025-06-05 | 2025-06-09 | 55,000 | — | $0 | 55,000 | SEC↗ |
| ANNX Annexon, Inc. | A Award deriv | 2024-06-05 | 2024-06-07 | 44,000 | — | $0 | 44,000 | SEC↗ |
| ANNX Annexon, Inc. | P Buy | 2023-12-26 | 2023-12-28 | 350,000 | $2.88 | $1.01M | 7,406,024 | SEC↗ |
| ANNX Annexon, Inc. | A Award deriv | 2023-06-08 | 2023-06-12 | 24,000 | — | $0 | 24,000 | SEC↗ |
| ANNX Annexon, Inc. | P Buy | 2023-02-10 | 2023-02-14 | 2,647,058 | $6.80 | $18.00M | 7,056,024 | SEC↗ |
| ANNX Annexon, Inc. | P Buy deriv | 2022-07-07 | 2022-07-11 | 613,497 | $0.13 | $79.8K | 613,497 | SEC↗ |
| ANNX Annexon, Inc. | P Buy | 2022-07-07 | 2022-07-11 | 2,453,988 | $3.84 | $9.42M | 4,408,966 | SEC↗ |
| ANNX Annexon, Inc. | A Award deriv | 2022-06-09 | 2022-06-13 | 24,000 | — | $0 | 24,000 | SEC↗ |
| ANNX Annexon, Inc. | A Award deriv | 2021-06-02 | 2021-06-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | P Buy | 2021-01-08 | 2021-01-08 | 9,000,000 | $1.10 | $9.90M | 16,609,449 | SEC↗ |
| ANNX Annexon, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-28 | 2,812,543 | — | $0 | 0 | SEC↗ |
| ANNX Annexon, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-28 | 5,537,036 | — | $0 | 0 | SEC↗ |
| ANNX Annexon, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-28 | 4,016,573 | — | $0 | 0 | SEC↗ |
| ANNX Annexon, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-28 | 3,095,238 | — | $0 | 0 | SEC↗ |
| ANNX Annexon, Inc. | C Conversion | 2020-07-28 | 2020-07-28 | 1,754,978 | — | $0 | 1,754,978 | SEC↗ |
| ANNX Annexon, Inc. | P Buy | 2020-07-28 | 2020-07-28 | 200,000 | $17.00 | $3.40M | 1,954,978 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | P Buy | 2020-06-08 | 2020-06-09 | 3,700,000 | $1.10 | $4.07M | 7,609,449 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | A Award deriv | 2019-06-18 | 2019-06-19 | 21,400 | — | $0 | 21,400 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | P Buy | 2019-01-10 | 2019-01-10 | 23,818 | $2.45 | $58.4K | 5,621,835 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | P Buy | 2019-01-09 | 2019-01-10 | 20,000 | $2.39 | $47.8K | 5,598,017 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | P Buy | 2019-01-08 | 2019-01-10 | 20,000 | $2.20 | $44.0K | 5,578,017 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | P Buy | 2019-01-07 | 2019-01-07 | 20,000 | $2.18 | $43.6K | 5,558,017 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | P Buy | 2019-01-04 | 2019-01-07 | 20,000 | $2.12 | $42.4K | 5,538,017 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | P Buy | 2019-01-03 | 2019-01-07 | 20,000 | $2.08 | $41.6K | 5,518,017 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | P Buy | 2019-01-02 | 2019-01-02 | 20,000 | $1.94 | $38.8K | 5,498,017 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | P Buy | 2018-12-31 | 2019-01-02 | 20,000 | $1.75 | $35.0K | 5,478,017 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | P Buy | 2018-12-28 | 2019-01-02 | 20,000 | $1.72 | $34.4K | 5,458,017 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | P Buy | 2018-12-27 | 2018-12-27 | 20,000 | $1.67 | $33.4K | 5,438,017 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | P Buy | 2018-12-26 | 2018-12-27 | 20,000 | $1.69 | $33.8K | 5,418,017 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | P Buy | 2018-12-21 | 2018-12-27 | 20,000 | $1.84 | $36.8K | 5,398,017 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | P Buy | 2018-12-20 | 2018-12-20 | 20,000 | $1.85 | $37.0K | 5,378,017 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | P Buy | 2018-12-19 | 2018-12-20 | 20,000 | $1.92 | $38.4K | 5,358,017 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | P Buy | 2018-12-18 | 2018-12-20 | 20,000 | $1.99 | $39.8K | 5,338,017 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | P Buy | 2018-12-14 | 2018-12-14 | 20,000 | $2.00 | $40.0K | 5,318,017 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | P Buy | 2018-12-13 | 2018-12-14 | 20,000 | $2.02 | $40.4K | 5,298,017 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | P Buy | 2018-12-12 | 2018-12-14 | 20,000 | $2.05 | $41.0K | 5,278,017 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | P Buy | 2018-12-11 | 2018-12-11 | 20,000 | $2.09 | $41.8K | 5,258,017 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | P Buy | 2018-12-10 | 2018-12-11 | 20,000 | $2.13 | $42.6K | 5,238,017 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | P Buy | 2018-12-07 | 2018-12-11 | 20,000 | $2.14 | $42.8K | 5,218,017 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | P Buy | 2018-12-06 | 2018-12-06 | 20,000 | $2.18 | $43.6K | 5,198,017 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | P Buy | 2018-12-04 | 2018-12-06 | 20,000 | $2.10 | $42.0K | 5,178,017 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | P Buy | 2018-12-03 | 2018-12-06 | 20,000 | $1.99 | $39.8K | 5,158,017 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | P Buy | 2018-11-30 | 2018-11-30 | 20,000 | $1.98 | $39.6K | 5,138,017 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | P Buy | 2018-11-29 | 2018-11-30 | 20,000 | $2.01 | $40.2K | 5,118,017 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | P Buy | 2018-11-28 | 2018-11-30 | 20,000 | $1.94 | $38.8K | 5,098,017 | SEC↗ |
| VTL VITAL THERAPIES INC | S Sale | 2018-09-17 | 2018-09-17 | 7,044,777 | $0.29 | $2.04M | 0 | SEC↗ |
| VTL VITAL THERAPIES INC | S Sale | 2018-09-14 | 2018-09-17 | 447,500 | $0.36 | $161.1K | 7,044,777 | SEC↗ |
| VTL VITAL THERAPIES INC | S Sale | 2018-09-13 | 2018-09-17 | 3,890,000 | $0.50 | $1.95M | 7,492,277 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | P Buy | 2018-06-28 | 2018-06-29 | 1,818,182 | $3.85 | $7.00M | 5,078,017 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | A Award deriv | 2018-06-20 | 2018-06-22 | 21,400 | — | $0 | 21,400 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2018-06-14 | 2018-06-15 | 12,500 | — | $0 | 12,500 | SEC↗ |
| VTL VITAL THERAPIES INC | A Award deriv | 2018-05-23 | 2018-05-25 | 29,538 | — | $0 | 29,538 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | P Buy | 2018-03-23 | 2018-03-23 | 1,000 | $5.00 | $5.0K | 3,259,835 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | P Buy | 2018-03-21 | 2018-03-23 | 4,000 | $4.85 | $19.4K | 3,258,835 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | P Buy | 2018-03-20 | 2018-03-21 | 5,400 | $4.97 | $26.8K | 3,254,835 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | P Buy | 2018-03-19 | 2018-03-21 | 7,600 | $4.96 | $37.7K | 3,249,435 | SEC↗ |
| VTL VITAL THERAPIES INC | P Buy | 2017-12-13 | 2017-12-14 | 50,000 | $5.57 | $278.5K | 11,382,277 | SEC↗ |
| VTL VITAL THERAPIES INC | P Buy | 2017-12-12 | 2017-12-14 | 50,000 | $5.40 | $270.0K | 11,332,277 | SEC↗ |
| VTL VITAL THERAPIES INC | P Buy | 2017-12-11 | 2017-12-11 | 50,000 | $4.96 | $248.0K | 11,282,277 | SEC↗ |
| VTL VITAL THERAPIES INC | P Buy | 2017-12-08 | 2017-12-11 | 50,000 | $4.92 | $246.0K | 11,232,277 | SEC↗ |
| VTL VITAL THERAPIES INC | P Buy | 2017-12-07 | 2017-12-11 | 50,000 | $4.77 | $238.5K | 11,182,277 | SEC↗ |
| VTL VITAL THERAPIES INC | P Buy | 2017-09-14 | 2017-09-14 | 30,000 | $4.25 | $127.5K | 11,132,277 | SEC↗ |
| VTL VITAL THERAPIES INC | P Buy | 2017-09-13 | 2017-09-14 | 50,000 | $4.13 | $206.5K | 11,102,277 | SEC↗ |
| VTL VITAL THERAPIES INC | P Buy | 2017-09-12 | 2017-09-14 | 50,000 | $3.74 | $187.0K | 11,052,277 | SEC↗ |
| VTL VITAL THERAPIES INC | P Buy | 2017-09-08 | 2017-09-12 | 50,000 | $3.53 | $176.5K | 11,002,277 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | C Conversion deriv | 2017-07-05 | 2017-07-06 | 159,548 | — | $0 | 0 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | C Conversion deriv | 2017-07-05 | 2017-07-06 | 183,944 | — | $0 | 0 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | C Conversion deriv | 2017-07-05 | 2017-07-06 | 847,721 | — | $0 | 0 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | C Conversion deriv | 2017-07-05 | 2017-07-06 | 247,398 | — | $0 | 0 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | C Conversion | 2017-07-05 | 2017-07-06 | 144,773 | — | $0 | 144,773 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | P Buy | 2017-07-05 | 2017-07-06 | 33,333 | $15.00 | $500.0K | 178,106 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | P Buy | 2017-07-05 | 2017-07-11 | 1,034,482 | $14.50 | $15.00M | 3,037,042 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2017-06-15 | 2017-06-19 | 12,500 | — | $0 | 12,500 | SEC↗ |
| VTL VITAL THERAPIES INC | P Buy | 2017-06-14 | 2017-06-14 | 10,000 | $3.10 | $31.0K | 10,952,277 | SEC↗ |
| VTL VITAL THERAPIES INC | P Buy | 2017-06-13 | 2017-06-14 | 10,000 | $3.03 | $30.3K | 10,942,277 | SEC↗ |
| VTL VITAL THERAPIES INC | P Buy | 2017-06-12 | 2017-06-12 | 10,000 | $3.06 | $30.6K | 10,932,277 | SEC↗ |
| VTL VITAL THERAPIES INC | P Buy | 2017-06-09 | 2017-06-12 | 10,000 | $3.17 | $31.7K | 10,922,277 | SEC↗ |
| VTL VITAL THERAPIES INC | P Buy | 2017-06-08 | 2017-06-12 | 10,000 | $3.10 | $31.0K | 10,912,277 | SEC↗ |
| VTL VITAL THERAPIES INC | P Buy | 2017-06-07 | 2017-06-07 | 10,000 | $3.21 | $32.1K | 10,902,277 | SEC↗ |
| VTL VITAL THERAPIES INC | P Buy | 2017-06-06 | 2017-06-07 | 10,000 | $3.19 | $31.9K | 10,892,277 | SEC↗ |
| VTL VITAL THERAPIES INC | A Award deriv | 2017-05-23 | 2017-05-25 | 63,031 | — | $0 | 63,031 | SEC↗ |
| VTL VITAL THERAPIES INC | P Buy | 2017-03-27 | 2017-03-27 | 3,750,000 | $4.00 | $15.00M | 10,882,277 | SEC↗ |
| NONE Aerpio Pharmaceuticals, In | P Buy | 2017-03-15 | 2017-03-17 | 1,120,000 | $5.00 | $5.60M | 3,241,835 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2016-06-16 | 2016-06-20 | 12,500 | — | $0 | 12,500 | SEC↗ |
| VTL VITAL THERAPIES INC | A Award deriv | 2016-05-24 | 2016-05-26 | 30,239 | — | $0 | 30,239 | SEC↗ |
| VTL VITAL THERAPIES INC | P Buy | 2015-10-28 | 2015-10-29 | 400,000 | $5.50 | $2.20M | 7,132,277 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2015-06-10 | 2015-06-12 | 5,000 | — | $0 | 5,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | P Buy | 2015-04-22 | 2015-04-22 | 420,000 | $8.25 | $3.46M | 2,002,560 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | P Buy | 2014-11-25 | 2014-11-26 | 5,000 | $13.18 | $65.9K | 1,582,560 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | P Buy | 2014-11-24 | 2014-11-25 | 5,000 | $13.88 | $69.4K | 1,577,560 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | P Buy | 2014-11-21 | 2014-11-24 | 5,000 | $14.73 | $73.7K | 1,572,560 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | P Buy | 2014-11-20 | 2014-11-21 | 5,000 | $14.70 | $73.5K | 1,567,560 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | P Buy | 2014-11-19 | 2014-11-20 | 5,000 | $14.85 | $74.3K | 1,562,560 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | P Buy | 2014-11-18 | 2014-11-19 | 5,000 | $13.84 | $69.2K | 1,557,560 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | P Buy | 2014-11-17 | 2014-11-18 | 5,000 | $12.94 | $64.7K | 1,552,560 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | P Buy | 2014-11-14 | 2014-11-17 | 5,000 | $11.91 | $59.5K | 1,547,560 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | P Buy | 2014-11-13 | 2014-11-14 | 5,000 | $11.56 | $57.8K | 1,542,560 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | P Buy | 2014-11-12 | 2014-11-13 | 3,900 | $12.20 | $47.6K | 1,537,560 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | P Buy | 2014-11-12 | 2014-11-13 | 1,100 | $10.85 | $11.9K | 1,533,660 | SEC↗ |
| VTL VITAL THERAPIES INC | P Buy | 2014-10-08 | 2014-10-09 | 74,286 | $17.50 | $1.30M | 6,732,277 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | C Conversion deriv | 2014-09-22 | 2014-09-24 | 4,577,315 | — | $0 | 0 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | C Conversion deriv | 2014-09-22 | 2014-09-24 | 8,013,003 | — | $0 | 0 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | C Conversion deriv | 2014-09-22 | 2014-09-24 | 3,931,085 | — | $0 | 0 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | C Conversion deriv | 2014-09-22 | 2014-09-24 | 457,728 | — | $0 | 0 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | P Buy | 2014-09-22 | 2014-09-24 | 150,000 | $15.00 | $2.25M | 1,771,688 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | C Conversion | 2014-09-22 | 2014-09-24 | 1,621,688 | — | $0 | 1,621,688 | SEC↗ |
| VTL VITAL THERAPIES INC | P Buy | 2014-06-03 | 2014-06-04 | 339 | $13.61 | $4.6K | 6,651,724 | SEC↗ |
| VTL VITAL THERAPIES INC | P Buy | 2014-06-03 | 2014-06-04 | 6,261 | $14.03 | $87.8K | 6,657,985 | SEC↗ |
| VTL VITAL THERAPIES INC | P Buy | 2014-06-02 | 2014-06-04 | 7,900 | $12.45 | $98.4K | 6,651,385 | SEC↗ |
| VTL VITAL THERAPIES INC | C Conversion deriv | 2014-04-23 | 2014-04-23 | 3,550,638 | — | $0 | 0 | SEC↗ |
| VTL VITAL THERAPIES INC | C Conversion deriv | 2014-04-23 | 2014-04-23 | 2,589,764 | — | $0 | 0 | SEC↗ |
| VTL VITAL THERAPIES INC | P Buy | 2014-04-23 | 2014-04-23 | 360,966 | $12.00 | $4.33M | 6,643,485 | SEC↗ |
| VTL VITAL THERAPIES INC | C Conversion | 2014-04-23 | 2014-04-23 | 6,140,402 | — | $0 | 6,282,519 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | C Conversion deriv | 2014-03-25 | 2014-03-27 | 525,021 | — | $0 | 0 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | C Conversion deriv | 2014-03-25 | 2014-03-27 | 260,873 | — | $0 | 0 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | C Conversion | 2014-03-25 | 2014-03-27 | 1,441,265 | — | $0 | 1,441,265 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | P Buy | 2014-03-25 | 2014-03-27 | 91,295 | $17.00 | $1.55M | 1,532,560 | SEC↗ |